Document is current
Any future updates will be listed below
-
Authors
Meyer, Nora
Hauprich, Julia
Breuing, Jessica
Hellbrecht, Irma
Wahlen, Sarah
Könsgen, Nadja
Bühn, Stefanie
Becker, Monika
Blödt, Susanne
Carl, Günther
Follmann, Markus
Frenz, Stefanie
Langer, Thomas
Nothacker, Monika
Schaefer, Corinna
Pieper, Dawid
-
Funding
Funding for this research was provided by:
Private Universität Witten/Herdecke gGmbH
- License Information
-
More Information
Article History
Received: 14 September 2023
Accepted: 24 December 2023
First Online: 16 January 2024
Declarations
:
: This study was approved by the University Witten/Herdecke Ethics Committee (160/2021). All procedures were performed in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from all participants.
: Not applicable.
: MB was involved in the development of patient versions of oncology in Germany. SBl and MN are representatives of the AWMF, which receives constant financial support from the GGPO and is involved in methodological counseling for CPGs in oncology and other CPGs. MF is a representative publisher of patient versions in oncology in Germany and is involved in the methodological counseling of CPGs and patient versions in oncology. TL is a representative publisher of patient versions of oncology in Germany. CS was involved in the development of patient versions in oncology in Germany until 2019 and is responsible for the development of patient versions of the National Program for Disease Management Guidelines (NDMG) and their methodological refinement. All other authors declare no competing interests.
